Gujarat Kidney and Super Speciality Complete Financial Statements
In FY2025, Gujarat Kidney and Super Speciality (GKSL) reported revenue ₹13 Cr, net profit ₹3 Cr and EPS ₹0.47, with a net profit margin of 23.1% and ROE of 11.1%. Full financial statements from FY2022 to FY2025 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore GKSL Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
GKSL Revenue, Net Profit & EBITDA — Year-on-Year Growth
GKSL YoY (Sept 2024 vs Sept 2025) — revenue +44.4%, expenses +60.0%. Review GKSL earnings multiple to evaluate earnings-based valuation against sector peers.
GKSL Income Statement — Revenue, EBITDA & Net Profit
Gujarat Kidney and Super Speciality revenue ₹13 Cr, EBITDA ₹5 Cr, net profit ₹3 Cr, EPS ₹0.47 (2025) — net profit margin 23.1%. For live price, earnings ratios and company overview, see Gujarat Kidney and Super Speci stock price NSE.
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Dec 2024 |
|---|---|---|---|---|---|---|
| Revenue | 13 | 10 | 15 | 23 | 9 | 12 |
| Expenses | 8 | 7 | 7 | 16 | 5 | 7 |
| EBITDA | 5 | 3 | 9 | 7 | 5 | 5 |
| Operating Profit Margin % | 40.00% | 27.00% | 57.00% | 30.00% | 52.00% | 39.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 |
| Profit Before Tax | 4 | 2 | 8 | 5 | 4 | 4 |
| Tax | 1 | 0 | 2 | 1 | 1 | 1 |
| Net Profit | 3 | 1 | 5 | 4 | 3 | 3 |
| Earnings Per Share (₹) | 0.47 | 0.22 | 0.85 | 0.52 | 0.65 | 0.52 |
GKSL Balance Sheet — Assets, Liabilities & Shareholders' Equity
GKSL total assets ₹55 Cr, total equity ₹27 Cr, total liabilities ₹ Cr (2025) — ROE 11.1%.
| Particulars | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 55 | 21 | 4 | 4 |
| Current Assets | 22 | 7 | 1 | 1 |
| Fixed Assets | 31 | 14 | 0 | 3 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 24 | 7 | 4 | 1 |
| LIABILITIES | ||||
| Total Liabilities | ||||
| Current Liabilities | 7 | 6 | 0 | 0 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 27 | 11 | 0 | 0 |
| Share Capital | 11 | 0 | 0 | 0 |
| Reserves & Surplus | 15 | 2 | 0 | 0 |
GKSL Cash Flow Statement — Operating, Investing & Financing
Gujarat Kidney and Super Speciality operating cash flow ₹14 Cr, investing ₹-18 Cr, financing ₹6 Cr, net cash flow ₹2 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 |
|---|---|---|---|
| Operating Activities | 14 | 1 | 0 |
| Investing Activities | -18 | 0 | 0 |
| Financing Activities | 6 | -1 | 0 |
| Net Cash Flow | 2 | 1 | 0 |